Tekla Life Sciences Investors operates in the Investment offices sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tekla Life Sciences Investors with three other
companies in this sector in UNITED STATES :
Invesco Advantage Municipal Income Trust II
sales of $36.85 million
Gladstone Capital Corporation
of which 100%
was Investment Income), and
BlackRock Municipal Income Trust
Tekla Life Sciences Investors reported sales of $39.07 million
September of 2020.
decrease of 0.0%
versus 2019, when the company's sales were $39.09 million.